NCT04212949

Brief Summary

The present study aims to investigate the efficacy of repetitive transcranial magnetic stimulation of the motor cortex combined with transforaminal epidural steroid injection in patients with chronic lumbar radiculopathy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 8, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 23, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 30, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2020

Completed
Last Updated

December 30, 2019

Status Verified

December 1, 2019

Enrollment Period

1 year

First QC Date

December 23, 2019

Last Update Submit

December 25, 2019

Conditions

Keywords

lumbar radiculopathyrTMSTESItreatment

Outcome Measures

Primary Outcomes (5)

  • Low back and leg pain

    Low back and leg pain will be evaluated with a 10-cm horizontal visual analogue scale (VAS) ranging from "0 cm" (no pain) to "10 cm" (intolerable pain).

    before treatment (T0)

  • Low back and leg pain

    Low back and leg pain will be evaluated with a 10-cm horizontal visual analogue scale (VAS) ranging from "0 cm" (no pain) to "10 cm" (intolerable pain).

    1st hour after injection (T1)

  • Low back and leg pain

    Low back and leg pain will be evaluated with a 10-cm horizontal visual analogue scale (VAS) ranging from "0 cm" (no pain) to "10 cm" (intolerable pain).

    3rd week of treatment (T2)

  • Low back and leg pain

    Low back and leg pain will be evaluated with a 10-cm horizontal visual analogue scale (VAS) ranging from "0 cm" (no pain) to "10 cm" (intolerable pain).

    3rd month of treatment (T3)

  • Low back and leg pain

    Low back and leg pain will be evaluated with a 10-cm horizontal visual analogue scale (VAS) ranging from "0 cm" (no pain) to "10 cm" (intolerable pain).

    6th month of treatment (T4)

Secondary Outcomes (21)

  • Quality of life and activities of daily living

    before treatment (T0)

  • Quality of life and activities of daily living

    3rd week of treatment (T1)

  • Quality of life and activities of daily living

    3rd month of treatment (T2)

  • Quality of life and activities of daily living

    6th month of treatment (T3)

  • Neuropathic pain

    before treatment (T0)

  • +16 more secondary outcomes

Study Arms (2)

Repetitive transcranial magnetic stimulation following TESI

EXPERIMENTAL

Active repetitive transcranial magnetic stimulation will be performed to the patients with lumbar radiculopathy who receive transforaminal epidural steroid injection.

Device: Repetitive transcranial magnetic stimulation (rTMS)Drug: Transforaminal epidural steroid injection

Transforaminal epidural steroid injection

ACTIVE COMPARATOR

Transforaminal epidural steroid injection will be applied to the patients with lumbar radiculopathy.

Drug: Transforaminal epidural steroid injection

Interventions

Stimulation will be performed from the contralateral M1 cortex of the painful side. Each stimulation session will consist of 1500 pulses (30 trains of 5 seconds each, with an inter-train interval of 25 seconds) delivered at a frequency of 10 Hz. The stimulation intensity will be set at 80% of the resting motor threshold.

Repetitive transcranial magnetic stimulation following TESI

An epidural steroid injection under guidance of fluoroscopy is used to reduce inflammation at a lumbar spinal nerve root(s). The following drugs will be used for this procedure: 80mg/2ml triamcinolone acetonide (sinakort-A) and 1 mL 0.5% bupivacaine (marcaine)

Repetitive transcranial magnetic stimulation following TESITransforaminal epidural steroid injection

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged between 20-60 years
  • Symptoms lasting longer than 3 months
  • To be planned TESI due to root compression which is caused by lumbar disk herniation
  • To agree to participate in the study

You may not qualify if:

  • Lumbar spinal stenosis
  • Presence of clinical findings incompatible with MRI
  • Spinal disease (trauma / tumor)
  • Spondylodiscitis or inflammatory spondylitis
  • Presence of epilepsy
  • Presence of implanted medical devices such as pacemakers, insulin pumps
  • Intracranial metallic implant
  • Previous cranial surgery history
  • Brain tumor
  • Severe hearing and vision loss
  • To be applied TESI for the last six months
  • Presence of surgical history through lumbar region
  • Scoliosis
  • Spodilolistezis
  • Pregnancy
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University School of Medicine, Department of Physical Medicine and Rehabilitation

Istanbul, Turkey (Türkiye)

RECRUITING

Related Publications (6)

  • Kang SS, Hwang BM, Son HJ, Cheong IY, Lee SJ, Lee SH, Chung TY. The dosages of corticosteroid in transforaminal epidural steroid injections for lumbar radicular pain due to a herniated disc. Pain Physician. 2011 Jul-Aug;14(4):361-70.

    PMID: 21785479BACKGROUND
  • Attal N, Ayache SS, Ciampi De Andrade D, Mhalla A, Baudic S, Jazat F, Ahdab R, Neves DO, Sorel M, Lefaucheur JP, Bouhassira D. Repetitive transcranial magnetic stimulation and transcranial direct-current stimulation in neuropathic pain due to radiculopathy: a randomized sham-controlled comparative study. Pain. 2016 Jun;157(6):1224-1231. doi: 10.1097/j.pain.0000000000000510.

    PMID: 26845524BACKGROUND
  • Roussel NA, Nijs J, Meeus M, Mylius V, Fayt C, Oostendorp R. Central sensitization and altered central pain processing in chronic low back pain: fact or myth? Clin J Pain. 2013 Jul;29(7):625-38. doi: 10.1097/AJP.0b013e31826f9a71.

    PMID: 23739534BACKGROUND
  • Galhardoni R, Correia GS, Araujo H, Yeng LT, Fernandes DT, Kaziyama HH, Marcolin MA, Bouhassira D, Teixeira MJ, de Andrade DC. Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature. Arch Phys Med Rehabil. 2015 Apr;96(4 Suppl):S156-72. doi: 10.1016/j.apmr.2014.11.010. Epub 2014 Nov 28.

    PMID: 25437106BACKGROUND
  • Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipovic SR, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5.

    PMID: 25034472BACKGROUND
  • Sari S, Aydin ON, Guleser G, Kurt I, Turan A. Effect of transforaminal anterior epidural steroid injection on neuropathic pain, quality of sleep and life. Agri. 2015;27(2):83-8. doi: 10.5505/agri.2015.91489.

    PMID: 25944134BACKGROUND

MeSH Terms

Conditions

Radiculopathy

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Hakan Gündüz, Prof

    Marmara University

    STUDY CHAIR
  • Gülseren Akyüz, Prof

    Marmara University

    STUDY CHAIR

Central Study Contacts

Savaş Şencan, Asst. Prof

CONTACT

Canan Şanal Toprak, Asst. Prof

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2019

First Posted

December 30, 2019

Study Start

November 8, 2019

Primary Completion

November 8, 2020

Study Completion

December 8, 2020

Last Updated

December 30, 2019

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations